Global Marketplace - BIO International Convention 2023 | 4 June 2023 | Boston Convention and Exhibition Center, 415 Summer Street, Boston, MA 02210, USA

This new program provides exclusive Innovation Stage programming allowing delegations to present and network in real-time. Participants in the marketplace can pitch their hottest technologies among some of the world's most innovative companies and identify prospective partners to meet ahead of BIO Digital.

2023 Speakers

Jeffrey Abbott, PhD
CEO, Cytotronics

Mojisola Adeyeye
Director General, National Agency for Food and Drug Administration and Control

Micky Adriaansens
Minister of Economic Affairs and Climate Policy, the Netherlands

Noubar Afeyan, PhD
Founder and CEO, Flagship Pioneering

Lovisa Afzelius
Origination Partner, Flagship Pioneering

Nadim Ahmed
President and Chief Executive Officer, Cullinan Oncology

Armin Al Ameeri
Assistant Undersecretary for Public Health Policy and Licensing, United Arab Emirates

Tom Alapaattikoski, MSc
CEO, Brinter Inc

Philippe Alen, ACA
SVP, Head Business Development, Galapagos

Lina Aljuburi, PharmD, MS
Head, Regulatory Science Policy North America, Sanofi

Luis Alvarez, PhD
CEO/President, Theradaptive, Inc.

Virginia Amann
CEO/Founder, Entente Health & Science Communications

Stacy Amin
Partner, Morrison Foerster

Alvaro Amorrortu, MBA, MS
Chief Executive Officer, Mediphage Bioceuticals Inc.

Rachel Anatol
SVP, Science & Regulatory Affairs, Bio

Querida Anderson
Managing Editor, Fierce Biotech, Fierce Medtech, Fierce Pharma, and Fierce Healthcare

Derek Ansel
Executive Director, Therapeutic Strategy Lead, Rare Disease (worldwide Clinical Trials)

Jim Anthony
Executive Vice President and Global Head, Parexel Biotech

James Appleby
CEO, The Gerontological Society of America

Daniel Arlow, PhD
CEO, Ansa Biotechnologies, Inc.

Linda Armstrong
Head US Corporate Responsibility, President, US Novartis Foundation

Drew Armstrong
Executive Editor, Endpoints News

Kathleen Arntsen
President & CEO, Lupus and Allied Diseases Association, Inc.

Manish Arora, MPH, PhD
Co-Founder & CEO, Linusbio

Anup Arora
Founding Managing Director & CIO, K2 Healthventures

Pierre Arsene, MSc
Founder & CEO, Mursla Bio

Phyllis Arthur
Vice President, Infectious Disease & Emerging Science Policy Infectious Diseases, Biotechnology Innovation Organization (bio)

Derk Arts, MD, PhD
CEO and Founder, Castor

Yumiko Asano, MS
Head of Chugai Partnering, Chugai Pharmaceutical Co., Ltd.

Christopher Ashdown, BS
Research Associate, Lahara Bio

Kristen Axelsen
Secretary, Preparedness and Treatment Equity Coalition

Joey Azofeifa, PhD
CEO, Arpeggio Biosciences

Elizabeth Bailey
Managing Partner, RH Capital

Matthew Baker
Chief Technical Officer, Dxcover Ltd.

Michael Banyas
Program Manager, National Institute Minority and Health Disparities

Subin Baral
Global Deals Leader, Life Sciences, EY

Ritu Baral
Managing Director, Health Care - Biotechnology, TD Cowen

Stephen Barat, PhD
Senior Vice President and Therapeutics Division Head, Htg Molecular Diagnostics, Inc.

Robert Barrow
CEO, Mindmed, Inc.

Dror Bashan, ACA
President & CEO, Protalix Biotherapeutics

Lynn Baxter
Head of North America, Viiv Healthcare

Max Bayer
Staff Reporter, Fierce Biotech

Ginny Beakes-Read
Executive Director and Lead, Global Regulatory and R&D Policy, Amgen

Jacob Becraft, PhD
Co-Founder & CEO, Strand Therapeutics

Ann Beliën, PhD
CEO, Rejuvenate Bio

Hamilton Bennett
Associate Director, Vaccine Access and Partnerships, Moderna

Ekua Bentil
Education Specialist, World Bank

Cory Berkland, PhD
CEO, Bond Biosciences

Jeff Berkowitz
Chief Executive Officer, Real Endpoints

Rob Berlin
Head of US Regulatory Policy, GSK

Nicole Berry
SVP, Head of Americas Region, Illumina

Alexandra Beumer Sassi, PhD, RAC
Senior Director Cmc&quality, Voisin Consulting Life Sciences

Abhijit Bhatia, MBA
Chief Operating Officer, Rakuten Medical, Inc.

Laurent Bili
Ambassador to The United States, France

Andrew Bishop, MD
Founder and CEO, Mary Sula Bishop Center for Translational Neuroscience

Fritz Bittenbender
Head, US Public Affairs, Genentech

torbjorn Bjerke, MD
CEO, Synact Pharma

Stacy Blain, PhD
Co-Founder, Chief Scientific Officer, Concarlo Therapeutics

Jeffrey Bockman, PhD
Expert Advisor, Oncology, Lumanity Evp, Head of Oncology Practice, Bioconsulting Head of Oncology Center of Excellence, Lumanity

Karen Boezi
Member, Broadway Angels

Katie Bollbach
Executive Director, U.S. Arm of Partners in Health

Karol Bomsztyk, ACA
Chief Technology and Medical Officer, Matchstick Technologies Inc

Sara Bonstein
CFO, Insmed

Aarash Bordbar, PhD
Chief Technology Officer, Sinopia Biosciences

Eucharia Borden
Vice President of Programs and Health Equity, Family Reach

Harm-Jan Borgeld, PhD
Head Asia Pharma Partnering, Roche

Frank Borriello, PhD,MD
Chief Executive Officer, Alloplex Biotherapeutics

Torie Bosch
Editor, First Opinion, Stat

Greg Bosch, BA,MBA
CEO, Panavance Therapeutics, Inc.

Avirup Bose, PhD
Vice President of Business Development, Chinook Therapeutics

Susan Botegga
CLL Caregiver/patient Advocate

Robert Boyce, ACA
CEO, Plakous Therapeutics, Inc.

Brian Bradbury
Vice President, Amgen Inc.

Otis Brawley
Sidney Kimmel Comprehensive Cancer Center, School of Medicine Department of Epidemiology, Bloomberg School of Public Health

Jennifer Bright, MPA
Chief Strategy & Engagement Officer, Innovation and Value Initiative

Julianne Bruno
Vice President and Head of Program Management, Crispr Therapeutics

Karim Budhwani, PhD, DLA
CEO-Scientist, Cerflux, Inc.

Julie Bullock
Senior Vice President, Certara

Matthew Burkhardt
Director, B Labs

Christopher Burns
President and CEO, Venatorx Pharmaceuticals, Inc.

Clara Burtenshaw
Partner and Investor, Neo Kuma Ventures

Stuart Cable
Vice Chairman, Global Chair of M&A, Goodwin

Riccardo Canevari
CEO, Radiopharm Theranostics

Chris Carpenter
Executive Partner, Private Equity, Sofinnova Investments

Olivia Cavlan
Chief Corporate Development & Strategy Officer, Alchemab

Meenakshy Chakravorty, JD
Senior Counsel, Digital and Devices Ip, Sanofi

Ben Chandhok
Director of State Public Policy and Government Relations, Alnylam Pharmaceuticals

Hemmie Chang
Partner & Co-Chair, Life Sciences Group; Chair, Licensing & Strategic Alliances, Foley Hoag Llp

Rebecca Charnas Grant
Senior Director, Associate General Counsel, Genentech

Helen Chen
Global Sector Co-Head, Healthcare and Life Sciences and Greater China Managing Partner, Lek Consulting

Po Chen
CEO, Cancerfree Biotech

Weisheng Chen, PhD
Founder and CEO, Leveragen, Inc.

Irene Cheong
Executive Director, A*star Innovation and Enterprise

Yi-Juang Chern
Deputy Minister, National Science and Technology Council, Taiwan

Christian Chessman
Associate, Dla Piper Llp (us)

Lorraine Chiroiu

Mallikarjun Chityala, MBA
Founder and CEO, Fitabeo Therapeutics

Kang-Yell Choi, PhD
CEO, CK Regeon, Inc.

Jennifer Chow
Chief Executive Officer and Managing Director, Chimeric Therapeutics Limited

Sohini Chowdhury
Chief Program Officer, the Michael J. Fox Foundation for Parkinson's Research

Alexis Clark
Morehouse School of Medicine

David Cole, PhD
Prof, Accession Therapeutics Ltd

Robert Coleman, PhD, MBA
Co-Founder and CEO, Codagenix Inc.

Thomas Collet, PhD
President & CEO, Bilayer Therapeutics, Inc.

Viswa Colluru, PhD
CEO, Enveda Biosciences

John Concato
Associate Director, Office of Medical Policy, Cder, Fda

To Be Confirmed, PhD
Corporate and Business Development, Novartis

Todd Cooper
SVP, Corporate Affairs, Kymera Therapeutics

Ivan Cornella, PhD
Chief Scientific Officer, Covant Therapeutics

James Cornwall, PhD
SVP Business Development, Launch Therapeutics

Nicholas Cosenza
Senior Manager Government Affairs, Amgen

Jeff Cottrell, Ph D
Head of Neurodevelopment & Psychiatry, Novartis Institutes for Biomedical Research (nibr), Novartis

David Cox
Freelance Journalist and Broadcaster

Travis Coy, Aca
Vice President - Head of Transactions and M&a, Eli Lilly and Company

David Craig, Mba
President and CEO, Sarcomatrix Therapeutics Corp

Alan Crane, MBA
Entrepreneur Partner, Polaris Partners

Jack Crawford, MS
CEO, Demeetra Agbio, Inc

Kyriea Crudup
Molecular Technician, Care Point Labs

Marisa Cruz, MD
Chief Medical Officer, Empatica

Jasmin Cui
CEO and Co-Founder, Innocare

Kevin Curran, PhD
Scientific Advisor and Instructor, Biotech Primer

Michael Curry
President & CEO, Massachusetts League of Community Health Centers, Ma Health Equity Compact Founder

Jie D'Elia
Senior Vice President, Business Development, Oncology, Hematology & Cell Therapy, Bristol Myers Squibb

Paul Dabrowski
CEO, Synthego Corporation

Steven Damon, PhD
CEO, Micron Biomedical, Inc.

Steve Darnell, PhD
Principal Scientist, Dnastar, Inc.

Debanu Das, ACA
CEO, Xpose Therapeutics Inc.

Stephanie Davis
Program Specialist, National Insitutes Oh Health

Monica De Lazzari
Associate, DLA PIPER LLP (US)

Yogev Debbi, MBA
Co-Founder & CEO at Mana.Bio

Anthony DeBoer
VP, Business Development, Synaffix Bv

Nicole DeFeudis
Editor, Endpoints News

Stephane Degove, BSc
CEO, Atamyo Therapeutics

Julio Delgado
Department of Haematology, Hospital Clinic, Idibaps, University of Barcelona, Spain

Geraldine Deliencourt-Godefroy, PhD
Chief Scientific Officer, Sirona Biochem Corporation

David Dellamonica
Global Head of Digital Strategy, Astrazeneca

Pierre Delsaux
Director-General, Health Emergency and Preparedness Response Authority, European Commission

Jennifer Dent
President, Bio Ventures for Global Health

Atul Deshpande, PhD
Chief Strategy Officer, Peptilogics

Scott DeWire, PhD
US Head, Business Development & Licensing, Boehringer Ingelheim Pharmaceuticals, Inc.

John DeYoung
VP, Head of Patient Access and Support, Oncology, Pfizer Inc.

Rachel Diamant
CBO, Emendobio

Christian Dimaano, PhD
VP, Head of Clinical Affairs, Kinnate Biopharma

Anil Diwan, PhD
President & Exec. Chairman, Nanoviricides, Inc.

Lucas Donigian, MBA
Executive Director, Business Development, Zymeworks Inc.

Liam Donohue
Co-Founder and Managing Partner, 406 Ventures

Ken Drazan
Founder and CEO, Arsenal Biosciences, Inc.

Jeremy Duffield, MD, PhD, FRCP
Chief Scientific Officer, Prime Medicine

Tomasz Dylag

Julie Eastland
CEO, Harpoon Therapeutics

Celia Economides
Executive Vice President and Chief Financial Officer, Gritstone Bio

Danielle Economo
Senior Director, Science and Regulatory Affairs, Johnson & Johnson

Anne-Virginie Eggimann
Chief Regulatory Officer, Tessera Therapuetics

Falk Ehmann, MD, PhD

Nevan Elam
CEO, Rezolute Bio

Fiona Elwood, PhD
VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen

Mark Emalfarb, BA
Chief Executive Officer, Dyadic International, Inc

Yusuf Erkul, MD
Co-Founder & CEO, Kernal Biologics, Inc.

Amit Etkin, PhD,MD
Founder and CEO, Alto Neuroscience Inc

Seth Ettenbeurg
President and CEO, Bluerock Private Equity

Jay Evans
Chief Scientific and Strategy Officer, Inimmune Corporation

Eric Falcand
VP Head of Business Development & Licensing, Servier Europe

Gary Fanger, PhD
President & CEO, Rise Therapeutics. Llc

Maria Fardis
Venture Partner, Frazier Life Sciences

Joe Farmer
President and Chief Operating Officer, Zenas Biopharma

Christian Felter
Global Medical Franchise Head – RSV, Sanofi

Theresa Ferguson, PhD
Chief Business Officer, Predictive Oncology

Kathy Fernando
Senior Vice President and Global Head of The Partner of Choice Organization, Pfizer Inc.

Stephanie Fertig
Team Lead, Nih Seed Office

Howard Fillit, MD
Chief Science Officer, Alzheimer's Drug Discovery Foundation

Lynn Filpi, PhD
Asst. Director One Health & Antimicrobial Resistance Health Outcomes Division, Office of Science & Technology Policy, Executive Office of The President

Clare Fisher
Senior Vice President, Business Development and M&a, Beigene, Usa, Inc.

Alexander Fleming, MD
Founder and CEO, Kinexum

Katherine Foley
FDA Reporter, Politico

Cathy Foley
Chief Scientist, Australia

David Fontana, PhD
Chief Operating Officer, Umoja Biopharma

Kristen Fortney, PhD
Co-Founder & CEO, Bioage Labs

Joshua Fox
Member, Mintz

Don Frail, PhD
Senior Advisor, Frazier Life Sciences

Brian Freed, PhD
Chief Science Officer, Rheumagen, Llc

Brian Freeman, MD
CEO, Energesis Pharmaceuticals

George Freeman
Minister of Life Sciences, United Kingdom

Leonard Friedland
Vice President and Director Scientific Affairs and Public Health Vaccines, GSK

Stephen From, BSc
CEO, Aruna Bio

Patrick Gallagher, MBA, MPH
Chief Business Officer, Sensei Biotherapeutics

Shaan Gandhi
Head of Strategic Partnerships, Pfizer Ignite, Pfizer

Chris Garabedian
CEO, Xontogeny

Emily Gardel, JD
Patent Attorney, Dyno Therapeutics

Matthew Gardner

Pallavi Garg
Head, Global Oncology Products and Pipeline Strategy, Takeda Oncology

Eric Gascho
Vice President, Policy and Government Affairs, National Health Council

Dan Gebremedhin, MD
Partner, Flare Capital

Asha George
Executive Director, Bipartisan Commission on Biodefense

Jim Geraghty
Chairman, BVGH Guests

Aziz Ghaderpour, MA
Senior Researcher, Shaperon

Adam Gilbert, PhD
Executive Director and External Accelerator Lead, Pfizer

Ryan Gill, PhD
CEO, Co-Founder, Artisan Bio

Christoph Glaetzer
Global Head of Market Access, Janssen Pharmaceutical Companies of Johnson & Johnson

Jacob Glanville, PhD
Founder/CEO/President, Centivax, Inc.

Martin Gleave, MD
CMO, Sustained Therapeutics

Matt Gline
Chief Executive Officer, Roivant Sciences

Gregory Glover, MD,JD
Principal, Pharmaceutical Law Group Pc

Manijeh Goldberg, PhD
President & CEO, Privo Technologies Inc.

Zelanna Goldberg
Chief Medical Officer, Replicate Bioscience

Jennifer Goldsack
CEO, Digital Medicine Society (dime)

Ariane Gomes
Chief Scientific Officer, Baseimmune

Jennifer Good
Co-Founder, President & CEO, Trevi Therapeutics

Wyatt Gotbetter
Senior Vice President and Worldwide Head, Access Consulting, Parexel

Steven Gourlay, MBBS
Chief Executive Officer, Actinogen Medical Limited

J. Lance Grady
Head of Market Access, Avalere Health

James Graham, Bcom
CEO, Recce Pharmaceuticals Ltd

Julie Gralow

William Greene, MD
Chief Investment Officer, Hevolution Foundation

Joseph Greer
Co-Director, Cancer Outcomes Research & Education, Massachusetts General Hospital Cancer Center

Megan Grether, PhD
Global Head of Business Development & Licensing, Animal Health, Boehringer Ingelheim Animal Health

Merlin Greuel
Director, Bioscience Valuation BSV Gmbh

Linda Griffith
School of Engineering Professor of Teaching Innovation, MIT

Jonathan Grinstein, PhD
Senior Editor, Genetic Engineering News

Sheila Gujrathi
Venture Advisor, Orbimed

Anil Gulati, MD
Chairman & CEO, Pharmazz Inc

Francis Gurry
Prior Director General (october 1, 2008 Through September 2020), World Intellectual Property Organization (retired)

Sebastian Guth
President of Pharmaceuticals, Americas Region, Bayer Corporation

Kimberly Ha
CEO, KKH Advisors

Magali Haas, MD, PhD
CEO and President, Cohen Veterans Bioscience

Joe Hammang, PhD
ML Strategies, Llc

Bonnie Hammer
Senior Vice President, Research & Development, Invenra Inc.

Nadia Haque, ACA
Executive Director, Research Technologies, Pharma Partnering, Genentech

Kouki Harasaki, PhD, MBA
Founding/Managing Partner, Bioluminescence Ventures

Suzie Harborth
Chief Business Officer, Breakthrough Properties

Shin Hatou, MD
CEO, Cellusion

Sabine Haubenreisser
European Medicines Agency Liaison Official to The Food and Drug Administration, European Medicines Agency (EMA)

Michael Havert, PhD
Senior Vice President, Head of Us Regulatory, Cellular Biomedicine Group, Inc (CBMG)

Rick Hawkins
CEO & Chairman, Lumos Pharma

Kent Hawryluk
President & Chief Executive Officer, MBX Biosciences, Inc.

Angela Hayes
SVP Diversity and Inclusion, Brodeur Partners

Biao He, PhD
CEO and Founder, Blue Lake Biotechnology

Monica He
Head, Intl Policy & Gov Affairs, Organon

James Healy, MD, PhD
General Partner, Sofinnova Investments

Mary Hedley, PhD
Senior Scientific Fellow, Broad Institute of MIT and Harvard; Board Member, Eli Lilly

Mo Heidaran, PhD
Head of Translational and Regulatory Strategy, GC Therapeutics

James Helliwell, FRCP (C) , MD
CEO, Eupraxia Pharmaceuticals Inc.

Gábor Heltovics
Venture Partner, NLC - the European Healthtech Venture Builder

Lee Henderson, PhD
CEO, Vybion, Inc

Charles Henderson
Chief Executive Officer, American Diabetes Association® (ada)

Dave Hering
CEO, INVIVYD

Terry Hermiston, PhD
CEO, Coagulant Therapeutics Corporation

Volker Herrmann
CEO-Partner, Flagship Pioneering; Chief Executive Officer, Sonata Therapeutics

Matthew Hewitt, PhD,BA
Vice President, Technical Officer Cgt & Biologics, Charles River Laboratories

Matthew Hill, PhD
CEO, Elegen Corp.

Kate Hillier
Partner, Cooley Llp

Art Hirt
SVP, Vaccines Business Unit, Merck

David Hoey, ACA
President and CEO, Vaxxas

Vera Hoffman, MBA
CEO, Reveal Pharma

Robert Hoffman
President and CEO, Kintara Therapeutics, Inc.

Michael Holmes
CSO, Tessera Therapeutics

Joshua Hooks
AAAS Fellow, National Institute of Aging

Dan Housman, BA
CEO, Courage Therapeutics

Angelita Howard
Assistant Dean of Online Education, Morehouse School of Medicine

Ginger Hsiao
CIO, Gold Nest Capital

John Hsu, MD
CEO, Quivivepharma.Com

Chun-Hao Huang, PhD
CEO & Co-Founder, Algen Biotechnologies

Michel Hubert, PharmD
VP Corporate Development, Oxymo Technologies Inc.

Matthew Hudes

Richard Hughes
Partner, Epstein Becker Green

Sasha Huhalov
Search and Evaluation Lead, Takeda Pharmaceutical Company

Azer Hussain, PhD
Head of Quantitative Pharmacology and Pharmacometrics – Immuno/oncology, Merck

Kyle Hvidsten
Vice President, Head of Global Health Economics and Value, Sanofi

Anna Hyde
VP of Advocacy and Access, Arthritis Foundation

Marc Hymovitz

Hiroshi Ikeuchi, MBA
Sr. Manager, Global Business Development, Otsuka Pharmaceutical Co., Ltd.

Kyung-Soo Inn, ACA
Transforming the Future of Targeted Protein Degradation (tpd) with Spidem, Prazer Therapeutics

Kelly Irwin
Director of The Collaborative Care and Community Engagement Program, Massachusetts General Hospital Cancer Center

Cynthia Isaac
Managing Director, Syneos Health

Christina Isacson, Ph D
Partner, Lightstone Ventures

Vijay Iyengar, Md
Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy, Incyte

Monica Jablonski, Ph D
Founder and Cso, Oculotherapy

Margaret Jackson, Ph D
Ceo, Byomass

Sam Jackson, Md
Chief Medical Officer, Neuron23

Monica Jang
Senior Licensing Manager, Technology & Innovation Development Office (tido), Boston Children’s Hospital

Shreya Jani
Vice President, Corporate Affairs, Beigene, Usa, Inc.

Friedemann Janus, Ph D
Acting Head of Business Development & Licensing and Open Innovation, Bayer Pharmaceuticals

Debra Jennings
Head of Patient Access and Support, Oncology Business Unit at Takeda Oncology, Takeda Pharmaceuticals

Amanda Jezek
Senior Vice President Public Policy and Government Relations, Infectious Diseases Society of America (idsa)

David Johnson, Md
Chief Commercial Officer, Global Blood Therapeutics

Sabrina Johnson, M Sc
President & Ceo, Da Ré Bioscience

Ramsey Johnson
Founder and President, Outbio

Brian Johnston, Ph D
Ceo, Somagenics, Inc.

Carrie Jones
Partner, Health Advances

Troels Jordansen
Ceo, Glycostem Therapeutics

Lim Jui
Ceo, Sginnovate

Sanjay Kakkar
President & Ceo, Tranquis Therapeutics

Amir Kalali, Md
Co-Chair, Dtra

Byoung Cheol Kang
Vice President, Mirimgene Co. Ltd.

Sree Kant
Founder and Ceo, Bakx Therapeutics

Milky Kao, M Sc
Vp of Bd, Taho Pharmaceuticals Ltd.

Maha Katabi
General Partner, Sofinnova Investments

Hans Keirstead, Ph D
Chairman, Immunis Biomedical

Rebecca Keiser
Chief of Research Security Strategy and Policy, National Science Foundation (nsf)

Tucker Kelly
Executive Vice President, Chief Financial Officer and Treasurer, Deciphera Pharmaceuticals

Kacie Kelly
Chief Innovation Officer, Meadows Mental Health Policy Institute

Jason Kelly, Ph D
Co-Founder and Ceo, Ginkgo Bioworks

Annie Kennedy
Chief of Policy, Advocacy, & Patient Engagement, Everylife Foundation for Rare Diseases

Benjamin Kim, Ph D
Venture Principal, Playground Global

Jinwoo Kim, Ph D
the Founder and Ceo, Haii (human Ai Interaction)

Moonhyok Kim
Senior Manager, Aprogen, Inc.

Deog Joong Kim, Ph D
Ceo, Nurron Pharmaceuticals, Inc

Danny Kim
Head of Welt Usa, Welt Corp.

Cherngju Kim, Ph D
Cto, Aulbio

Kyu-Tae Kim, Ph D
Chief Business Officer, Pharos Ibio

Yongtae Kim, Ph D
Ceo, Mepsgen

Soo-Youl Kim, Ph D
Ceo, Ncc-Bio

Joshua Kime
Strategic Partnerships Manager, Andelyn Biosciences

Donald Kirkpatrick, Ph D
Chief Technology Officer, Interline Therapeutics

Sahil Kirpekar, Md
Chief Business Officer, Atai Life Sciences

Semra Kitchen, Ph D
Director, Business Development - Search and Evaluation, Gsk

Roger Kitterman, Mba
Co-Founder and Managing Partner, Mass General Brigham Ventures

Isaac Klein
Chief Scientific Officer, Dewpoint Therapeutics

Matthias Kleinz, Ph D,dvm
Evp, Translational Sciences, Upmc Enterprises

Jackie Kline
Vice President, Global Regulatory Affairs, Oncology, Amgen

Jeremy Knox
Head of Policy, Infectious Disease, Wellcome Trust

Angela Koehler
Associate Professor, Department of Biological Engineering, Mit

Peter Kolchinsky, Ph D
Founder and Managing Partner, Ra Capital

Neal Koller, Bs
Founder and Ceo, Alphyn Biologics, Inc.

Barbara Kosacz
Coo and General Counsel, Kronos Bio, Inc.

Davor Kosanic, Ph D
Ceo, Reconnect Labs Ag

Mathias Kroll, Ph D,mba,m Sc
Chief Commercial Officer, Qimr Berghofer Medical Research Institute

Neil Kumar, Ph D
Ceo and Founder, Bridgebio Pharma, Inc.

Kenichiro Kuninobu, Ph D, R Ph
Ceo, Feliqs Corporation

Sam Lai, Ph D
Founder & Interim Ceo, Mucommune, Llc

Jenny Laird
Vp, Search & Evaluation Neuroscience, Eli Lilly

Darius Lakdawalla, Ph D
Professor of Pharmaceutical Economics and Public Policy Quintiles Chair in Pharmaceutical and Regulatory Innovation; Director of
Research, Schaeffer Center, University of Southern California

Shaheen Lakhan, Md, Ph D, Faan
Chief Medical Officer, Click Therapeutics

Dirk Landgraf, Ph D
Vp, Dementia Discovery Fund, Sv Health Investors

Edward Jr. Lang
Chief Business Officer, Anheart Therapeutics

Robert Langer
David H. Koch Institute Professor, Massachusetts Institute of Technology

Joe Larsen
Vice President, Clinical Development, Locus Biosciences, Inc.

Donna La Voie
President & Ceo, Lavoiehealthscience

Corinne Le Goff, Mba, Pharm D
Ceo, Imunon, Inc.

Jeb Ledell, Bs
Chief Operating Officer, Aveo Oncology, Inc

Seth Lederman, Md
Chief Executive Officer, Tonix Pharmaceuticals Holding Corp.

Russel Ledet, Md, Ph D, Mba
Pediatrics/general Psychiatry/ Child and Adolescent Psychiatry Resident; Co-Founder and President, the 15 White Coats

Yuta Lee, Mba
Chief Executive Officer, Accelerated Biosciences Corp.

C Justin Lee, Ph D
Director, Institute for Basic Science, Center for Cognition and Sociality

Andy Lee
Co-Founder & Coo, Vincere Biosciences, Inc

Jennifer Leeds, Ph D
Executive Director, Novartis

Andrew Leger, Mba
Head of Us Bus Dev, Ferrer Internacional, S.A.

Theodore (ted) Lehman
Principal, Todd Strategy Group

Julianna Le Mieux
Deputy Editor in Chief, Genetic Engineering News

John Lepore
Svp Research, Gsk

Andrew Levin, Md, Ph D
Partner and Managing Director, Ra Capital Management

Stephen Levy, Ph D
Founding Partner, Cytequest

Jerry Li

Yuanpei Li, Aca
Ceo, Theranostec Inc

Cynthia Li, Ph D
Vp, Business and Corporate Development, Spotlight Therapeutics

Greg Licholai
Chief Medical and Innovation Officer, Icon

James Lillard
Senior Associate Dean of Research & Innovation, Morehouse School of Medicine

Han Lim
Chief Business Officer, Deepcure

Susan Limb, Md
Vice President of Clinical Science and Therapeutic Area Head for Pulmonary, 4 D Molecular Therapeutics

Bob Linke, Mba
Ceo, Osmol Therapeutics, Inc.

Craig Lipset
Co-Chair, Decentralized Trials & Research Alliance

Angus Liu
Senior Writer, Fierce Pharma/fierce Biotech

Sarah Lively, Ph D
Senior Director, External Innovation, Discovery, Product Development & Supply, Johnson & Johnson

Roger Longman
Founder and Chairman, Real Endpoints

Angelica Loskog, Ph D
Ceo, Lokon Pharma

Steven Lucio
Senior Principal, Pharmacy Solutions, Vizient

Scott Lundeen, Ph D,ms
Sr. Director of Acquisitions, Johnson & Johnson

Tia Lyles-Williams
Chief Executive Officer, Goffman Bougard, Inc.

David M Jackson, Ph D
Ceo, Ceria Therapeutics, Inc.

Sahaj Madhav, Mba
Director, Business Development, Amgen

Nadir Mahmood, Ph D
Chief Financial and Business Officer, Nkarta, Inc.

Maulik Majmudar, Md
Chief Medical Officer and Co-Founder, Biofourmis

Angele Maki, Ph D
Svp, Business Development, Recode Therapeutics

Andrea Malizia, Mba, Ph D
Ceo, Iama Therapeutics

Lesley Maloney
Regulatory Shaping Lead , Integrated Solutions & Regulatory Policy Lead, Digital Health, Genentech

Josh Mandel-Brehm, Mba
President & Chief Executive Officer, Camp4 Therapeutics

Meredith Manning
President, the Americas, Pharmaessentia Usa

Li Mao, Md
Vice President, General Manager of Research and Development and Chief Medical Officer, Sciclone Pharmaceuticals

Ian Marks
Director, Strategy & Solutions, Amazon Web Services

Peter Marks, Md,ph D
Director, Center for Biologics Evaluation and Research, Fda/cber/ddi

Chris Marsh
Co-Founder, Lhon Collective; Managing Director, Ubs

Tyler Martin
Chairman & Ceo, Aeolian Biotech

Petrina Martin Cherry
Vice President of Community Engagement and External Affairs, Boston Medical Center Health System

Olivier Martinon, Vmd
Vice President, External Innovation, Zoetis

Karen Martins
Chief, Antivirals and Antitoxins, Barda

John Maslowski Maslowski, Ms
Chief Commercial Officer, Forge Biologics

Osamu Matsuzaki, Ms
Board Director, Vice-Presidential Executive Officer, Asahi Kasei Pharma

B. Chandler May
Chief Executive Officer, Inflammatory Response Research, Inc.

Katie Mc Carthy
Director, Regulatory Policy and Intelligence, Abbvie

Owen Mc Carthy
President and Co-Founder, Medrhythms

Ally Mc Clure, Bs
Co-Founder, Biorankings

John Mc Donald, Jd, Mba
Corporate Vice President, Novo Nordisk

James Mc Intyre, Cfa
Vice President, Global Business Development & Licensing, Merck Animal Health

Grace Mc Mahon
Avp and Head, Pacific Bd&l, Merck

Taylor Mc Partland
Ceo, Scalehealth

Brian Mc Veigh, Clp, Cpa, Mba
Chairman, Chief Executive Officer, and Co-Founder, Code Biotherapeutics

Bruce Meadows
Data, Digital and Technology Managing Partner, Takeda Digital Ventures

Scott Megaffin
Ceo, Adiso Therapeutics

Shreefal Mehta
Director, Pulmokine Inc.

Innes Meldrum
President and Ceo, Reset Pharma

Michelle Mellion, Md
Senior Vice President, Head of Clinical Development, Pepgen

Sandeep Menon, Ph D
Chief Scientific Officer, Ai Digital Sciences & Senior Vp, Head of Early Clinical Development, Pfizer

Kate Mevis
Executive Director, Merck

Andrea Miele, Ph D
Assistant Professor of Pediatrics, University of Colorado School of Medicine

Christine Miller
Global Head of Esg, Beigene, Usa, Inc.

Alexis Miller
U.S. Lead, Global Regulatory Policy, Merck

Sandra Milligan, Md,jd
Head of Research and Development, Organon

Erin Mistry
Evp and Chief Commercial Officer, Coremedix

James Mock
Cfo, Moderna

Etienne Montagut, Mba
Chief Business Officer, Lantheus

Amy Moore, Ph D
Vp, Global Engagement and Patient Partnerships, Lungevity

Nathaniel Moorman, Ph D
Co-Founder, Readdi

Akifumi Morinaka, Mba, Ph D
Chief Business Officer, Rege Nephro Co., Ltd.

Rachel Morra, Ph D
Head of Scientific Partnerships and Alliances, Enterome

Christopher Mortko
Assoc Vp Business Development & Licensing, Merck

Anne Mostue
News Anchor, Bloomberg Media

Massoud Motamed, Ph D
Vice President of Quality Assurance and Analytics, Nanoscope Therapeutics Inc

Amanda Mott
Vice President, Us Market Access, Viiv Healthcare

John Murphy
Chief Policy Officer, Bio

Jomana Musmar
Senior Advisor and Dfo, Us Department of Health & Human Services

Shankar Musunuri, Mba, Ph D
Chairman, Chief Executive Officer, Co-Founder, Ocugen

Karthik Musunuri
Ceo, Advaite Inc.

Hassan Naqvi
Lead, Global Digital Health Commercialization, Astrazeneca

Madhu Natarajan
Head of Rare Diseases Drug Discovery Unit, Takeda

Alexander Natz
Secretary General, Eucope

Edward Neilan, Ph D,md
Chief Medical and Scientific Officer, National Organization for Rare Disorders

Gina Nellesen
Intellectual Property Counsel, Beigene Usa, Inc.

Frank Nestle, Md
Global Head of Research and Chief Scientific Officer, Sanofi

Lucas Nivon, Ph D
Co-Founder & Ceo, Cyrus Biotechnology

Victor Nizet
Ucsd Distinguished Professor, Vice Chair & Division Chief, University Pf California, San Diego

Carrie Northcott
Senior Director, Digital Medicine & Translational Imaging, Pfizer

Emile Nuwaysir, Ph D
Chief Executive Officer, Ensoma

Dawn O'connell
Assistant Secretary for Preparedness and Response, Us Department of Health and Human Services

Don O'sullivan, B Sc,ph D
Mr., Asher Biotherapeutics, Inc

Benjamin Oakes, Ph D
Co-Founder & Ceo, Scribe Therapeutics

Lydia Ogden, Ph D, Mpp
Global Public Health R&d Policy and Engagement Lead, Johnson & Johnson

Pete O Heeron, Ms
Ceo, Fibrobiologics

Bisola Ojikutu, Md,mph
Executive Director, Boston Public Health Commission, City of Boston

Sally Okun, Mhs
Executive Director, Clinical Trials Transformation Initiative

Matias Olsen
Public Affairs & Policy Manager, Eucope

Tuyen Ong, Md,mba
Ceo Ring Therapeutics and Ceo-Partner at Flagship Pioneering, Ring Therapeutics and Flagship Pioneering

Anekwe Onwuanyi
President, Association of Black Cardiologists

John Orwin, Mba
President & Ceo, Atreca, Inc.

Samir Ounzain, Ph D
Ceo & Scientific Co-Founder, Haya Therapeutics

Kevin Outterson
Executive Director, Carb-X

Vijayakanth Pagadala, Ph D
Chief Operating Officer, Glycan Therapeutics

Max Paganelli, Md, Ph D
Founder, Morphocell Technologies Inc.

Maria Palasis, Ph D
President and Chief Executive Officer, Lyra Therapeutics

Deborah Palestrant, Ph D, Mba
Partner, 5 Am Ventures

Rifat Pamukcu, Md
President & Ceo, Rxmp Therapeutics, Inc.

Lorenzo Paoletti
Managing Director, Biotech Investment, Truist Securities

Bumjoon Park, Ph D
Ceo / Cto, Prg Science & Technology

Seung Bum Park, Ph D
Ceo, Spark Biopharma, Inc

Yoon Jeong Park, Ph D
Cto, Nibec

Kevin Parker, Ph D
Co-Founder & Ceo, Cartography Biosciences

Jay Parrish
Venture Partner, Arch Venture Partners

Dan Passeri, M.Sc., Jd
Ceo, Cue Biopharma

Dharmesh Patel
President, Partnership to Advance Cardiovascular Health

Neela Patel
Chief Business Development Officer, Good Therapeutics

Shyam Patel
Director of Business Development, California Institute of Regenerative Medicine (crim)

Snehal Patel, Mba, Ms
Chief Executive Officer, Greenwich Lifesciences

Monika Paule, Aca
Ceo, Caszyme

Li Peng, Ph D
Chief Scientific Officer, Palleon Pharmaceuticals

Lucy Perez
Senior Partner, Mckinsey & Company

Jennifer Petter, Ph D
Founder and Cso, Arrakis Therapeutics, Inc

Allen Phelps, Cfe,cpp
Ceo, Iptalons, Inc.

Waranyoo Phoolcharoen
Chief Technology Officer and Co-Founder, Baiya Phytopharm. Co., Ltd

Anna Picciolo-Lehrke
Head of Global Business Development Neurology, Ucb Sa

Patrick Plues
Vice President Sga, Government Affairs and External Relations, Biotechnology Innovation Organization

Kevin Pong, Mba, Ph D
Chief Business Officer, Business Development, Anima Biotech Inc.

Robert Popovian
Founder, Conquest Advisors

Cynthia Porter Riggins
Head of Cmc Regulatory Affairs, Elevatebio

Caroline Pothet
Acting Head of Advanced Therapies, European Medicines Agency

William Potter, Aca
Chief Scientific Advisor, Praxis Bioresearch

Shilpa Prem
Corporate Counsel, Amazon Lab126

Lori Pressman, Mse
Independent, Consultant

Pavel Printsev, Ms
Director, Bd, Bridge Biotherapeutics, Inc

Dennis Purcell
Founder, Aisling Capital Llc

Emmet Purtill, Mba
Vice President Business Development, Nicox S.A.

Mohan Purushothaman, Ph D
Chairman & Ceo, Progentec Diagnostics, Inc.

Marco Quarta, Ph D
Ceo, Rubedo Life Sciences

Maha Radhakrishnan, Md
Group Svp, Chief Medical Officer, Biogen

Susan Raiola
President, Real Endpoints

Shobie Ramakrishnan
Chief Technology and Digital Officer, Gsk

Zoran Rankovic, Ph D
Director, Cbt Chemistry Centers, St. Jude Children’s Research Hospital

Kurt Rasmussen
Chief Scientific Officer, Delix Therapeutics, Inc.

Chris Reddick
Vice President, Head of R&d Health Equity, Takeda Pharmaceutical Company

Sashank Reddy, Ph D,md
Senior Medical Director, Johns Hopkins Technology Ventures

Gilly Regev, Aca
Ceo, Sanotize Research and Development Corp.

Paul Rennie, B Sc
Managing Director, Paradigm Biopharmaceuticals

Josh Resnick, Md
Senior Managing Director, Ra Capital Management

Gabriele Ricci
Chief Data & Technology Officer, Takeda Pharmaceutical Company

Geralyn Ritter
Evp for External Affairs and Esg Sustainability, Organon

Adam Roach
Vp and Head of Asia-Pacific, Beigene

Wayne Roberts
Ceo, Cancer Prevention & Research Institute of Texas (cprit)

Dolca Rogers
Quality Specialist, European Medicines Agency

Michael Rohr
Partner, Cooley

Luke Rosen
Co-Founder & Board Chair, Kif1 A.Org

Hugh Rosen
Professor of Molecular Medicine, the Scripps Research Institute

David Ross
Az Lead for Accumulus Synergy - Business Transformation, Orsse, Astrazeneca

Alexis Rovner, Ph D
Co-Founder & Ceo, 64 X Bio

Steven Rowe, Md
Executive Vice President and Chief Scientific Officer, Cystic Fibrosis Foundation

Nawal Roy
Founder and Ceo, Holmusk

Howard Rutman, Md, Mba
Chief Medical Officer, Xalud Therapeutics

Barbara Ryan
Board Member, Indivior; Senior Advisor, Life Sciences, Ey

Denise Sabatino, Ph D
Research Associate Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania and The Children's Hospital of Philadelphia

Cibele Sabido David, Ph D
Head of Next Generation Pharma Assets, Zambon Group Spa

Luisa Salter-Cid
Chief Scientific Officer, Pioneering Medicines, Flagship Pioneering

Martin Sanders, Md
Ceo, Io Therapeutics, Inc

Antonella Santuccione Chadra, Md
Chief Medical Officer, Altoida

James Sapirstein, Mba, Pharm D
Chairman, President and Ceo, First Wave Biopharma, Inc.

Anthony Sasse, Fracp
Dr, Snoretox Ltd

Ken Savin, Ph D

Cornelius Schmaltz
Head of Unit, Executive Agency for Small and Medium Enterprises (easme)

Emmett Schmidt
Vice President, Merck

Michael Schrader, Mba
Ceo, Vaxess Technologies

Howison Schroeder, M Sc
President & Ceo, Neuro-Innovators, Llc

Duane Schulthess
Ceo, Vital Transformation

Maggie Scully, Ph D
Partnership Development Manager, Frederick National Laboratory for Cancer Research

Stefano Serafini
Executive Vice President - Europe, Iptalons, Inc.

Joseph Sevilla
Research Associate, Harvard T.H. Chan School of Public Health

Rutul Shah, Ms
Chief Operating Officer, Precigen, Inc.

Dhvanit Shah, Ph D
President & Chief Executive Officer, Garuda Therapeutics, Inc.

Bavani Shankar
Vp, Corporate Development, Biohaven Pharmaceuticals

Kan Shao, Ph D
President, Dream Tech, Llc

Gary Shapiro, Ph D
Vice President, Discovery Biology, Affini-T Therapeutics

Elaine Shapland, Ph D
Senior Director of Build Technology Development, Ginkgo Bioworks

Aneeb Sharif
Senior Vice President (us) & Associate Director (uk), Reputation and Risk Management, Syneos Health

Khushboo Sharma
Chief Regulatory Innovation Officer, Accumulus Synergy

Ofer Sharon, Mba, Md
Ceo, Oncohost

Jylana Sheats, Mps,ph D
Civic Science Fellow, the Aspen Institute

Kathy Sherman
Executive Director, State & International Government Affairs, Amgen

Michael Sherman
Venture Parture, Ra Capital Management

Jim Sherner
Executive Director and Head of Policy, Advocacy, and Government Affairs, Seqirus

Victor Shifrin, Ph D
Ceo, Immunochem Therapeutics, Llc

I-Hung Shih, Ph D
Managing Director and Co-Head, Biotech Private Investments, Wellington Management

Nick Shipley
Chief Advocacy Officer, Bio

Brain Silver, Jd
Cfo, Tscan Therapeutics

Peter Silverstone
Ceo & Director, Zylorion Health

Lauren Silvis
Senior Vice President of External Affairs, Tempus

Amy Simon, Md
Chief Medical Officer, Beam Therapeutics

Ruchita Sinha
General Partner, Av8 Ventures

Michael Sitzman
Us Chair Life Sciences Patent Litigation, Dla Piper Llp (us)

Claire Skentelbery
Director General, Europabio

Ana Slipicevic, Ph D
Ceo, One Carbon Therapeutics Ab

Elizabeth Smith, Mba, Ph D
Vice President, Business Development, Fzata, Inc.

Charlotte Smith
Senior Vice President, Public Affairs, Travere

Kim Smith
Svp Research and Development, Viiv Healthcare

Giovanni Spagnolli, Ph D
Cto, Sibylla Biotech Srl

Daniel Speidel, Ph D
Managing Director, Breakpoint Therapeutics Gmbh

Reed Sprague, Mba
Executive Director, Stanford Medicine - Industry Relations

Kristin Stephenson, Jd
Director, Office of Strategy & Alliances - Pediatric Translational Neuroscience, St. Jude Children's Research Hospital

Judy Stewart
Svp, Us Commercial Vaccines, Gsk

Ruedi Stoffel
Head of Partnering Roche Diagnostics, Roche Diagnostics

Paul Stoffels
Ceo and Chairman, Galapagos Therapeutics (glpg)

Lesley Stolz
Vice President, Johnson & Johnson Innovation

Laura Stoppel, Ph D
Principal, Ra Capital

Samantha Dale Strasser, Bs, Mphil, Ph D
Co-Founder and Chief Science Officer, Pepper Bio

Weiguo Su
Ceo, Hutchmed

Arthur Suckow
Ceo, Dtx Pharma

Eddie Sullivan, Ph D
Co-Founder, President & Ceo, Sab Biotherapeutics

Tim Sullivan
Cfo, Apellis Pharmaceuticals, Inc.

Kena Swanson, Ph D
Vice President, Viral Vaccines, Pfizer

Matthew Szuhaj, Bs,mba
Managing Director Finance & Enterprise Performance/real Estate & Location Strategy, Deloitte Consulting Llp

Jack Talley, Bs
Ceo, Mitotherapeutix Llc

Amir Tamiz
Director, Division of Translational Research, Ninds

Litjen Tan
Chief Strategy Officer, Immunize.Org

Erica Taylor
Chief Marketing Officer and Vp, Genentech

Carolyn Taylor
Executive Director, Global Focus on Cancer

Petro Terblanche, Md
Afrigen Biologics, and Who Mrna Hub

Oliver Thiel
Ama Site Head Executive Director, Process Development, Drug Substance Technologies, Amgen

Senthil Nathan Thirugnana Sambandam, Mba
Founder & Ceo, Phanes Biotech

Karl Thor, Ph D
Cso, Dignify Therapeutics

Maia Thrift-Perry
Global Head of Patient Advocacy and Public Health Policy, Beigene, Usa, Inc.

Vivian Tian, Ph D
Sr. Director, Business Development & Licensing, Biocytogen Pharmaceuticals (beijing)

A.J. Tibbetts
Intellectual Property Attorney, Shareholder, Greenberg Traurig, Llp

Hideki Tomioka, Ph D
Director, Member of The Board Cso, Research & Development, Funpep Co., Ltd.

Annelyn Torres-Reveron, Ph D
Co-Founder and Ceo, Sur180 Therapeutics, Inc

Robert Towarnicki, Ms
President & Ceo, Sirpant Immunotherapeutics, Inc.

Nolan Townsend
Ceo, Lexeo

Raphael Townshend, Ph D
Founder and Chief Executive Officer, Atomic Ai

Sharon Townson
Chief Technology Officer, Monte Rosa Therapeutics

Giovanni Traverso
Assistant Professor, Massachusetts Institute of Technology

Bijal Trivedi
Senior Science Editor, National Geographic

Alan Trounson, Ph D
Ceo, Cartherics Pty Ltd

Robert Truckenmiller
Head of Us Market Access, Gsk

Karmen Trzupek
Sr Director, Scientific Programs, Rare-X

Vasileios Tsanidis
Lawyer, Innovation Procurement Advisor, European Innovation Council (eic)/business Acceleration Services Sector (bas), European Commission (ec)

Henrietta Ukwu
Executive Vice President, Chief Regulatory Officer, Novavax

Aminu Umar-Sadiq
Ceo and Managing Director, Nigeria Sovereign Investment Authority (nsia)

Arda Ural
Ey Americas Health Sciences & Wellness Leader

Jakob Uszkoreit
Ceo, Inceptive Nucleics, Inc.

Yoshiaki Uyama
Director, Pharmaceuticals and Medical Devices Agency

Varun Valsaraj
Senior Manager, Analytics Center of Excellence, Sas Institute

Jasper Van Grunsven
Vice President, General Manager—general Medicine, Amgen

Madoo Varma, Ph D
Vice President of Business Development, Dna Script

Chris Varma, Ph D
Co-Founder, Chairman and Ceo, Frontier Medicines

Karthik Venkatakrishnan, Ph D
Vice President, Global Head of Quantitative Pharmacology, Emd Serono

Dominique Verhelle, Mba,ph D
Co-Founder, Chief Executive Officer and Chief Scientific Officer, Nextrna

Laura Veroneau
Managing Director, Optum Ventures

Patrice Verpillat
Head of The Real World Evidence (rwe) Workstream, European Medicines Agency

Christopher Viehbacher
President and Chief Executive Officer, Biogen

Jo Viney, Ph D
Founder, President & Chief Executive Officer, Seismic Therapeutic

Shelia Violette, Ph D
Cso, President of Research, Q32 Bio Inc.

Vlad Vitoc, Mba, Md
Ceo, Maia Biotechnology, Inc.

Christine Von Raesfeld
Founder and Ceo, People with Empathy

Kent Wakeford
Co-Founder and Co-Ceo, Form Bio

Greg Walden
Former Chair, House Energy and Commerce Committee

Rowan Walrath
Life Sciences Reporter, Boston Business Journal

Ian Walters, Md, Mba
Chief Executive Officer, Chairman and Director, Portage Biotech

Emma Wamsley
Ceo, Gsk

Yakun Wan, Ph D
Ceo, Shanghai Novamab Biopharmaceuticals Co., Ltd.

Rong Wang, Aca
Chief Operating and Financial Officer, Nuvox Therapeutics

Jonathan Wang
Chief Business Officer, Zai Lab

Michael Ward
Vice President of Public Policy and Government Relations, Alliance for Aging Research

Mike Ward
Global Head of Life Sciences & Healthcare Thought Leadership, Clarivate

Brent Warner, Mba
President, Gene Therapy, Poseida Therapeutics

Jim Wassil, Ms
Chief Operating Officer, Vaxcyte

Bradley (brad) Watts
Chief Counsel for The Intellectual Property Subcommittee on The Senate Judiciary Committee, U.S. Senate

Michael Webb, Ma, Mba
Chief Executive Officer, Cxl Ophthalmics, Inc.

Scott Weintraub
Svp, Us Commercial Operations, Alexion, Astrazeneca Rare Disease

Michelle Werner
Ceo of Alltrna Bio; Ceo and Partner, Flagship Pioneering

James Weyhenmeyer
President at Auburn Research & Technology Foundation, Auburn University

Angela Whatley, Ph D
Senior Director Regulatory Affairs, Bridgebio

Emma Wheatley
Deputy General Counsel and Head of Collaborations, Cepi

Phyllis Whiteley
Venture Partner, Playground Global

Kendal Whitlock
Head of Digital Optimization, Rwe Clinical Trials, Walgreens

John Wilbanks
Head of Data, Biogen Digital Health

Stephen Willard, Jd
Ceo and Director, Nrx Pharmaceuticals

Juliet Williams, Ph D
Senior Vice President, Head of Research, Kymera Therapeutics

Charity Williams
Partner, Cooley Llp

Angela Willis
Svp, Market Access, Better Therapeutics

Susan Winckler, R Ph
Ceo, Reagan-Udall Foundation

Steve Winitsky
Vice President, Technical, Parexel

Matthew Wolfgang
Associate Professor, University of North Carolina at Chapel Hill

Chad Womack
Vice President, National Stem Programs and Tech Initiatives, Uncf

Tony Wood
Chief Scientific Officer, Gsk

George Xixis, Jd,ma
Associate Vice Chancellor - Transactions - Bridge Innovation and Business Development, University of Massachusetts Medical School

Caroline Xu
Co-Founder & Ceo, Vigeneron

Se Hwan Yang, Ph D
President / Ceo, Neoimmunetech Inc

Rong Yang
Ceo, Fosun Pharma Usa Inc.

Jin-San Yoo, Ph D
Ceo/president, Pharmabcine Inc.

Richard Young
, Mit/whitehead Institute

Peter Young
Senior Venture Partner, Pappas Capital

Dan Young
Shareholder, Wolf Greenfield

Todd Young
(r-In), Sponsor of The Pasteur Act

Jung Sun Yum, Ph D
Ceo & Cto, Cha Vaccine Institute

Cindy Zadikoff, Md, M Sc
Senior Medical Director in Neuroscience Clinical Development, Abbvie

Dennis Zaller, Ph D
Chief Scientific Officer, Rome Therapeutics

Rachel Zolot Schwartz
Chief Business Officer, Volastra Therapeutics

Ananya Zutshi

2023 Sponsors

DOUBLE HELIX SPONSORS:
• Amgen
• Avantor
• Genentech
• GSK
• Lilly
• Merck
• Sanofi

HELIX SPONSORS:
• Johnson&Johnson
• Pfizer
• Takeda
• Travere

PREMIER SPONSORS:
• Biogen
• Boehringer Ingelheim
• Bristol Myers Squibb
• Daiichi-Sankyo
• Maryland Life Sciences
• Novartis
• Servier
• Vertex

CHAMPION SPONSORS:
• Alexion
• Alzheimer's Drug Discovery Foundation
• Asahi Kasei
• Foley Hoag
• Fujifilm
• Hevolution
• KBI
• Parexel
• SciClone
• Simcere
• Vial

CONFERENCE SPONSORS:
• Abcellera
• City of Phoenix
• Cytiva
• Fosun Pharma
• Labcorp
• MBHB
• MedChemBio
• NovoTech
• Otsuka
• Phrma
• Syneos Health
• Twist